Introduction to ERA

ERA Consulting was founded as a result of a management buy-out of a regulatory function within a toxicology contract research organisation, to attain independence. As a result, our company can boast a cumulative history of experience spanning over 20 years, since the early days of the regulation of products derived from biotechnology in the late 1980s.

Our parent company was founded in Germany in 1993, and a subsidiary in London followed shortly thereafter in 1995 in response to the establishment of the European Medicines Agency (EMEA). In response to requests from our growing US client base, ERA has founded the joint venture company US Biologic Regulatory Services LLC (US-BRS). In addition, in the autumn of 2004 we launched a new office in Brisbane, Australia. Details of our locations can be found on the Office Locator page of this website.

During the evolution of our activities during the past 20 years, we have striven continuously to upgrade and update our scientific expertise, reaching a balance in the team between long years of experience and the infusion of know-how in cutting edge technologies. We remain dedicated to the concept of specialising in biopharmaceutical products, in which we have the necessary experience and an unparalleled track record of success. Our team has grown over these years to incorporate new talent, not only in the scientific field, but also in business development and client services.

Not only do we have the necessary scientific expertise, but also the facilities and equipment for a professional approach to project work. We have invested both in hardware and software, a keystone to our philosophy, in order to provide the resources that the discerning client requires, a factor that differentiates us from others in the field. Indeed, few, if any other consulting groups of our size can provide, as we do fully equipped conference rooms and the logistic advantage of locations in Germany, London (close to the EMEA) Washington, DC, and Brisbane for agency interactions.

We cordially invite you to contact us for more information on our consulting organisation. Needless to say, we would be delighted to have the opportunity to present ourselves in more detail in a personal meeting.

Last, but not least, we would like to express our thanks to our clients and business associates for their support and constructive collaborations during the past 20 years. We are pleased to be able to add value and provide our services to such a large number of companies throughout the world, ranging from the large transnational pharmaceutical companies, to smaller biotech start-ups. ERA has the experience and flexibility to provide individual solutions for all strategic regulatory affairs requirements in our industry.

Christopher Holloway